These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 15304160)

  • 1. Human papillomavirus genotyping by a polymerase chain reaction-based genechip method in cervical carcinoma treated with neoadjuvant chemotherapy plus radical surgery.
    Huang HJ; Huang SL; Lin CY; Lin RW; Chao FY; Chen MY; Chang TC; Hsueh S; Hsu KH; Lai CH
    Int J Gynecol Cancer; 2004; 14(4):639-49. PubMed ID: 15304160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus genotype in cervical cancer: a population-based study.
    Lai CH; Huang HJ; Hsueh S; Chao A; Lin CT; Huang SL; Chao FY; Qiu JT; Hong JH; Chou HH; Chang TC; Chang CJ
    Int J Cancer; 2007 May; 120(9):1999-2006. PubMed ID: 17266033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of human papillomavirus genotype in prognosis of early-stage cervical cancer undergoing primary surgery.
    Lai CH; Chang CJ; Huang HJ; Hsueh S; Chao A; Yang JE; Lin CT; Huang SL; Hong JH; Chou HH; Wu TI; Huang KG; Wang CC; Chang TC
    J Clin Oncol; 2007 Aug; 25(24):3628-34. PubMed ID: 17704412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus genotype as a major determinant of the course of cervical cancer.
    Lombard I; Vincent-Salomon A; Validire P; Zafrani B; de la Rochefordière A; Clough K; Favre M; Pouillart P; Sastre-Garau X
    J Clin Oncol; 1998 Aug; 16(8):2613-9. PubMed ID: 9704710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus detection in cervical carcinoma tissues and paraaortic lymph nodes by the polymerase chain reaction.
    Park JS; Chee YH; Namkoong SE; Han SK; Kim TE; Lee HY; Kim SJ
    Gynecol Oncol; 1994 Jun; 53(3):344-51. PubMed ID: 8206408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of human papillomavirus DNAs in cervical carcinoma and risk of lymph node metastasis: association with 72-kilodalton metalloproteinase immunostaining.
    Garzetti GG; Ciavattini A; Lucarini G; Goteri G; Menso S; De Nictolis M; Romanini C; Biagini G
    Cancer; 1998 Mar; 82(5):886-92. PubMed ID: 9486578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus-31-related types predict better survival in cervical carcinoma.
    Huang LW; Chao SL; Hwang JL
    Cancer; 2004 Jan; 100(2):327-34. PubMed ID: 14716768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of detection of human papillomavirus 16 DNA in cervical carcinoma tissues by Southern blot hybridisation and nested polymerase chain reaction.
    Chang DY; Hsieh CY; Chen RJ; Lee SC; Huang SC
    J Med Microbiol; 1995 Dec; 43(6):430-5. PubMed ID: 7473676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The predictive value of human papillomavirus testing for the outcome of patients conservatively treated for stage IA squamous cell cervical carcinoma.
    Costa S; Sideri M; Negri G; Venturoli S; Santini D; Casadio C; Sandri MT; Bucchi L
    J Clin Virol; 2015 Sep; 70():53-57. PubMed ID: 26305820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
    de Sanjose S; Quint WG; Alemany L; Geraets DT; Klaustermeier JE; Lloveras B; Tous S; Felix A; Bravo LE; Shin HR; Vallejos CS; de Ruiz PA; Lima MA; Guimera N; Clavero O; Alejo M; Llombart-Bosch A; Cheng-Yang C; Tatti SA; Kasamatsu E; Iljazovic E; Odida M; Prado R; Seoud M; Grce M; Usubutun A; Jain A; Suarez GA; Lombardi LE; Banjo A; Menéndez C; Domingo EJ; Velasco J; Nessa A; Chichareon SC; Qiao YL; Lerma E; Garland SM; Sasagawa T; Ferrera A; Hammouda D; Mariani L; Pelayo A; Steiner I; Oliva E; Meijer CJ; Al-Jassar WF; Cruz E; Wright TC; Puras A; Llave CL; Tzardi M; Agorastos T; Garcia-Barriola V; Clavel C; Ordi J; Andújar M; Castellsagué X; Sánchez GI; Nowakowski AM; Bornstein J; Muñoz N; Bosch FX;
    Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph node human papillomavirus DNA positivity in uterine cervical cancers and its relationship with prognostic factors.
    Baser E; Can F; Unlukaplan M; Ayhan A
    Int J Gynecol Cancer; 2011 Jan; 21(1):117-22. PubMed ID: 21330836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and identification of human papillomavirus using a PCR-restriction fragment mass polymorphism assay.
    Lee JK; Hong YJ; Um TH; Lee EH; Chi HS; Koh JS; Yim HW; Cha YJ
    Mol Med Rep; 2011; 4(4):645-50. PubMed ID: 21503578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of HPV infection with prognosis after neoadjuvant chemotherapy in advanced uterine cervical cancer.
    Nobeyama H; Sumi T; Misugi F; Okamoto E; Hattori K; Matsumoto Y; Yasui T; Honda K; Iwai K; Ishiko O
    Int J Mol Med; 2004 Jul; 14(1):101-5. PubMed ID: 15202023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPV-negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis.
    Rodríguez-Carunchio L; Soveral I; Steenbergen RD; Torné A; Martinez S; Fusté P; Pahisa J; Marimon L; Ordi J; del Pino M
    BJOG; 2015 Jan; 122(1):119-27. PubMed ID: 25229645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of high-risk HPV status in advanced cervical cancers and pelvic lymph nodes.
    Füle T; Csapó Z; Máthé M; Tátrai P; László V; Papp Z; Kovalszky I
    Gynecol Oncol; 2006 Mar; 100(3):570-8. PubMed ID: 16325245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different outcome of invasive cervical cancer associated with high-risk versus intermediate-risk HPV genotype.
    de Cremoux P; de la Rochefordière A; Savignoni A; Kirova Y; Alran S; Fourchotte V; Plancher C; Thioux M; Salmon RJ; Cottu P; Mignot L; Sastre-Garau X
    Int J Cancer; 2009 Feb; 124(4):778-82. PubMed ID: 19035459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The genotypes and prognostic significance of human papillomaviruses in cervical cancer.
    Chen TM; Chen CA; Wu CC; Huang SC; Chang CF; Hsieh CY
    Int J Cancer; 1994 Apr; 57(2):181-4. PubMed ID: 8157355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus typing with a polymerase chain reaction-based genotyping array compared with type-specific PCR.
    Lin CY; Chao A; Yang YC; Chou HH; Ho CM; Lin RW; Chang TC; Chiou JY; Chao FY; Wang KL; Chien TY; Hsueh S; Huang CC; Chen CJ; Lai CH
    J Clin Virol; 2008 Aug; 42(4):361-7. PubMed ID: 18455959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
    Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
    Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders.
    van Ham MA; Bakkers JM; Harbers GK; Quint WG; Massuger LF; Melchers WJ
    J Clin Microbiol; 2005 Jun; 43(6):2662-7. PubMed ID: 15956381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.